These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia. Mallofré C; Castillo M; Morente V; Solé M Mod Pathol; 2003 Mar; 16(3):187-91. PubMed ID: 12640096 [TBL] [Abstract][Full Text] [Related]
30. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection. Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824 [TBL] [Abstract][Full Text] [Related]
31. PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma. Lumachi F; Ermani M; Marino F; Iacobone M; Baldessin M; Cappuzzo G; Zanella S; Favia G Anticancer Res; 2006; 26(2A):1305-8. PubMed ID: 16619538 [TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer. Pastuszewski W; Dziegiel P; Krecicki T; Podhorska-Okolow M; Ciesielska U; Gorzynska E; Zabel M Anticancer Res; 2007; 27(1A):335-42. PubMed ID: 17352251 [TBL] [Abstract][Full Text] [Related]
33. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM Cancer; 1998 Jun; 82(11):2262-9. PubMed ID: 9610708 [TBL] [Abstract][Full Text] [Related]
34. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Kleer CG; Giordano TJ; Braun T; Oberman HA Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524 [TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma. Suthipintawong C; Wejaranayang C; Vipupinyo C J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508 [TBL] [Abstract][Full Text] [Related]
36. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome. Brustmann H Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981 [TBL] [Abstract][Full Text] [Related]
37. [P53 protein expression and proliferative potential in non-recurrent and recurrent meningiomas]. Miyagami M; Kanou T; Nakamura S No To Shinkei; 1996 Aug; 48(8):719-25. PubMed ID: 8797205 [TBL] [Abstract][Full Text] [Related]
38. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity. Prayson RA Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291 [TBL] [Abstract][Full Text] [Related]
39. Clinical significance of angiogenesis in rectal carcinoid tumors. Onogawa S; Tanaka S; Oka S; Morihara M; Kitadai Y; Sumii M; Yoshihara M; Shimamoto F; Haruma K; Chayama K Oncol Rep; 2002; 9(3):489-94. PubMed ID: 11956615 [TBL] [Abstract][Full Text] [Related]
40. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis. Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]